Outcrop Groundwater Prospecting, Drilling, and Well Construction in Hard Rocks in Semi-arid Regions

This chapter presents some recommendations for prospecting, drilling and well construction in hard rocks in semi-arid regions. Considering that these conditions are present in many countries where technology is not always available, the chapter concentrates on the most basic and simple methods to plan where best to drill and maximize success through the direct observation of rock types, weathering and fracturing. The advantage for the geologist and hydrogeologist in an arid or semi-arid environment is that vegetation is normally scarce and the weathering layer thin, allowing a direct view of the rock in circumstances impossible in other climate regions of the world. The close observation of the weathering material, and especially of the fracture network, mainly the fracture density, dip, extension and interconnection, can provide important information for a field hydrogeologist who can then plan the best place for drilling. The most appropriate drilling technique, if available in the area, is rotary percussion, also designated as down-the-hole drilling, with drilling rates that can achieve 100 m per day in normal circumstances. This allows a well to be constructed in about two days, essential in the case of disaster relief. Finally, some information is given about well construction, careful planning of the work, protection to preserve the water quality, avoiding problems of partial or total collapse of the hole during construction or of the well and after completion, and how to avoid direct contact between the surface or sub-surface waters with the aquifer along the walls of the well to protect the well and the aquifer against contamination

Apoptotic profiling of chronic myeloid leukaemia patients' platelets ex vivo before and after treatment with Imatinib

Chronic myeloid leukaemia (CML) is a malignancy of the haematopoietic stem cells. The first line of treatment for CML, especially in developing countries, remains the first-generation tyrosine kinase inhibitor, Imatinib. Patients with CML are frequently diagnosed with platelet abnormalities. However, the specific mechanism of platelet abnormalities in CML remains unclear and poorly understood. The aim of this study was therefore to determine the apoptotic profiles of CML patients ex vivo on platelets before and after treatment with Imatinib. Blood samples of healthy volunteers and CML patients at diagnosis and after 6 months treatment with Imatinib were collected. Platelet counts, viability and activation were determined. Results showed that CML patients' platelet counts were elevated upon diagnosis and these levels statistically significantly decreased after 6 months of treatment. Platelet activation was significantly increased after 6 months of treatment compared to levels at diagnosis (P-value < .05). Similarly, platelet apoptosis was also increased after 6 months of treatment. Abnormalities in platelet functioning found in this study may partly be due to clonal proliferation of haematopoietic cells in CML patients, specifically of megakaryocyte precursors as well as the inhibition of platelet tyrosine kinase's and the inhibition of platelet-derived growth factor.Cancer Association of South Africa; Medical Research Council of South Africa; National Research Foundation; School of Medicine Research Committee of the Faculty of Health Sciences, University of Pretoria; Struwig-Germeshuysen Research Trust.http://wileyonlinelibrary.com/journal/cbfhj2022HaematologyInternal MedicinePhysiolog

Die Weinzucht unter Glas /

Mode of access: Internet

Multi-targeted directed ligands for Alzheimer’s disease: design of novel lead coumarin conjugates

Alzheimer’s Disease (AD) is a neurodegenerative disease characterized by central nervous system insults with progressive cognitive (memory, attention) and non-cognitive (anxiety, depression) impairments. Pathophysiological events affect predominantly cholinergic neuronal loss and dysfunctions of the dopaminergic system. The aim of the current study was to design multi-targeted directed lead structures based on the coumarin scaffold with inhibitory properties at two key enzymes in disease relevant systems, i.e. acetylcholinesterase (AChE) and monoamine oxidase B (MAO-B). Conventional and microwave synthetic methods were utilized to synthesize coumarin scaffoldbased novel morpholino, piperidino, thiophene and erucic acid conjugates. Biological assays indicated that the coumarin–morpholine ether conjugate BPR 10 was the most potent hMAO-B inhibitor. The coumarin–piperidine conjugates BPR 13 and BPR 12 were the most potent inhibitors of eeAChE at 100 μM and 1 μM, respectively. Molecular modelling studies were conducted with Accelrys® Discovery Studio® V3.1.1 utilising the published hMAO-B (2V61) and hAChE (4EY7) crystal structures. Compound BPR 10 occupies both the entrance and substrate cavities of the active site of MAO-B. BPR 13 resides in both the peripheral anionic site (PAS) and the catalytic anionic site (CAS) of hAChE. This study demonstrated that the coumarin scaffold serves as a promising pharmacophore for MTDLs design

Profiling of chronic myeloid leukaemia patients’ platelets ex vivo before and after treatment with Imatinib

National Research Foundationhttps://drive.google.com/file/d/1Gz3oxfuueA20GIhBs5kU_mPMInKX59_n/view?usp=sharinghttps://drive.google.com/drive/folders/1D47D8jiOKhGh21gaGMqa9QcfTTZugNQ5?usp=sharinghttps://drive.google.com/drive/folders/1ogPuGWp3a1fMD7-uvYO2KgZMfF1cvris?usp=sharin

Apoptotic profiling of chronic myeloid leukaemia patients' platelets ex vivo before and after treatment with Imatinib

Chronic myeloid leukaemia (CML) is a malignancy of the haematopoietic stem cells. The first line of treatment for CML, especially in developing countries, remains the first-generation tyrosine kinase inhibitor, Imatinib. Patients with CML are frequently diagnosed with platelet abnormalities. However, the specific mechanism of platelet abnormalities in CML remains unclear and poorly understood. The aim of this study was therefore to determine the apoptotic profiles of CML patients ex vivo on platelets before and after treatment with Imatinib. Blood samples of healthy volunteers and CML patients at diagnosis and after 6 months treatment with Imatinib were collected. Platelet counts, viability and activation were determined. Results showed that CML patients' platelet counts were elevated upon diagnosis and these levels statistically significantly decreased after 6 months of treatment. Platelet activation was significantly increased after 6 months of treatment compared to levels at diagnosis (P-value < .05). Similarly, platelet apoptosis was also increased after 6 months of treatment. Abnormalities in platelet functioning found in this study may partly be due to clonal proliferation of haematopoietic cells in CML patients, specifically of megakaryocyte precursors as well as the inhibition of platelet tyrosine kinase's and the inhibition of platelet-derived growth factor.Cancer Association of South Africa; Medical Research Council of South Africa; National Research Foundation; School of Medicine Research Committee of the Faculty of Health Sciences, University of Pretoria; Struwig-Germeshuysen Research Trust.http://wileyonlinelibrary.com/journal/cbfhj2022HaematologyInternal MedicinePhysiolog

Determination of the size segregated chemical composition and on line size distribution measurement of aerosol during cloud formation.

In order to observe changes in size distribution and chemical composition of aerosol particles during the formation of orographic clouds size segregated aerosol samples were collected at two sites of different altitudes in the west of the Vosges. Number size distributions covering a size range between 0.001 and 0.8 &mu;m were monitored by means of a CNC - diffusion-battery-(CNC-DB) setup located at a site in the condensation level. During the condensation phase a growth of the small particles is observed. After the cloud event the aerosol does not recover it&#39;s original diameter. At the same time the mass of Sulfur in the aerosol in the small size range is elevated leading to a smaller Mass median diameter (MMD) of the Sulfur size distribution measured with a Berner impactor. The reason for this enrichment is an uptake of Sulfur from the gasphase during the cloud formation